key: cord-0900133-jt6ont5j authors: Lu, S.; Duplat, D.; Leon, C.; Benitez-Bolivar, P.; Villota, S. D.; Veloz-Villavicencio, E.; Arevalo, V.; Jaenes, K.; Guo, Y.; Cicek, S.; Robinson, L.; Peidis, P.; Pearson, J. D.; Woodgett, J.; Mazzulli, T.; Ponce, P.; Restrepo, S.; Gonzalez, J. M.; Bernal, A.; Guevara-Suarez, M.; Pardee, K.; Cevallos, V. E.; Gonzalez, C.; Bremner, R. title: Multicenter international assessment of a SARS-CoV-2 RT-LAMP test for point of care clinical application date: 2022-02-27 journal: nan DOI: 10.1101/2022.02.27.22271548 sha: 0148d1e9ba704782d06ca6b4221488d7531a2862 doc_id: 900133 cord_uid: jt6ont5j Continued waves, new variants, and limited vaccine deployment mean that SARS-CoV-2 tests remain vital to constrain the COVID-19 pandemic. Affordable, point-of-care (PoC) tests allow rapid screening in non-medical settings. Reverse-transcription loop-mediated isothermal amplification (RT-LAMP) is an appealing approach. A crucial step is to optimize testing in low/medium resource settings. Here, we optimized RT-LAMP for SARS-CoV-2 and human {beta} actin, and tested clinical samples in multiple countries. TTTT linker primers did not improve performance, and while guanidine hydrochloride, betaine and/or Igepal-CA-630 enhanced detection of synthetic RNA, only the latter two improved direct assays on nasopharygeal samples. With extracted clinical RNA, a 20 min RT-LAMP assay was essentially as sensitive as RT-PCR. With raw Canadian nasopharygeal samples, sensitivity was 100% (95% CI: 67.6% - 100%) for those with RT-qPCR Ct values [≤] 25, and 80% (95% CI: 58.4% - 91.9%) for those with 25 > Ct [≤] 27.2. Highly infectious, high titer cases were also detected in Colombian and Ecuadorian labs. We further demonstrate the utility of replacing thermocyclers with a portable PoC device (FluoroPLUM). These combined PoC molecular and hardware tools may help to limit community transmission of SARS-CoV-2. Finally, using a PoC instrument that enables de-centralized deployment of the RT-LAMP assay, 1 0 0 we describe the application of this test on raw unpurified samples. This direct RT-LAMP 1 0 1 strategy reduces the barrier to establishing testing capacity by overcoming the need for 1 0 2 laboratory infrastructure for RNA extraction or specialized thermocycling and optical monitoring All oligos (Table 1) were ordered from IDT and dissolved with DNase/RNase-free water 1 0 9 at 100μM concentration. The purification method for F3, B3, LF and LB was standard desalting, 1 1 0 and the purification method for FIP and BIP was HPLC. Oligos for each primer set were 1 1 1 combined to make a 10X mix based on required concentrations. O R F 1 a -C -F 3 C T G C A C C T C A T G G T C A T G T T 4 9 8 -5 1 7 i n G e n e B a n k : M T 0 0 7 5 4 4 . 1 Z h a n g Y e t a l . [ T T C T C T G G A T T T A A C A C A C T T 2 4 2 0 -2 4 4 1 i n G e n e B a n k : M T 0 0 7 5 4 4 . 1 A s 1 _ L F T T A C A A G C T T A A A G A A T G T C T G A A C A C T O R F 1 a o f S A R S -C o V -2 A s 1 _ L B T T G A A T T T A G G T G A A A C A T T T G T C A C G A s 1 e _ F I P T C A G C A C A C A A A G C C A A A A A T T T A T T T T T C T G T G C A A A G G A A A T T A A G G A G A s 1 e _ B I P T A T T F 1 a -B 3 A G T C T G A A C A A C T G G T G T A A G 3 3 1 1 -3 3 3 1 i n G e n e B a n k : e n e E 1 -T B I P T T G C T A G T T A C A C T A G C C A T C C T T A T T T T G G T T T T A C A A G A C T C A C G T G e n e N -A -F 3 T G G C T A C T A C C G A A G A G C T 2 8 5 2 5 -2 8 5 4 3 G e n e N -A -B 3 T G C A G C A T T G T T A G C A G G A T 2 8 7 2 2 -2 8 7 4 1 i n G e n e B a n k : M T 0 0 7 5 4 4 . 1 G e n e N -A -L F G G A C T G A G A T C T T T C A T T T T A A T T T G G A T C T T T G T C A T C C 2 9 2 9 0 -2 9 3 1 1 i n G e n e B a n k : M T 0 0 7 5 4 4 . 1 N -g e n e -L F T T C C T T G T C T G A T T A G T T C G e n e N o f S A R S -C o V -2 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted February 27, 2022. ; https://doi.org/10.1101 https://doi.org/10. /2022 N -g e n e -L B A C C T T C G G G A A C G T G G T T N -g e n e -F I P T G C G G C C A A T G T T T G T A A T C A G C C A A G G A A A T T T T G G G G A C N -g e n e -B I P C G C A T T G G C A T G G A A G T C A C T T T G A T G G C A C C T G T G T A G N -g e n e -T F I P C G C A T T G G C A T G G A A G T C A C T T T T T T T G A T G G C A C C T G T G T A G N -g e n e -T B I P T B 3 G A C T T G A T C T T T G A A A T T T G G A T C T 2 9 2 9 9 -2 9 3 2 3 i n G e n e B a n k : T T T T G C T G G G G T G T T G A A G G T C S u m m a r y o f t h e a b o v e p r i m e r s e t s i n o p t i m i z a t i o n p h a s e s 1 1 4 a P h a s e 1 : P r i m e r s c r e e n i n g w i t h 3 0 c o p i e s o f s y n t h e t i c S A R S -C o V -2 R N A ( a l l p r i m e r s e t s ) 1 RT-LAMP. Batch 2: 120 positive and 120 negative samples were randomly chosen, and re- The optimized RT-LAMP recipes for various conditions were in Table 2 . The optimized RT-1 8 8 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) The copyright holder for this preprint this version posted February 27, 2022. ; https://doi.org/10.1101 https://doi.org/10. /2022 LAMP assays were evaluated in Colombian and Ecuadorian laboratories with CFX96 TM Real-1 8 9 Time System (BIO-RAD) using 96-well plates (BIO-RAD, Cat. No. HSP9601). threshold; Error bars represent mean ± standard deviations. To develop a sensitive RT-LAMP assay, we used only 30 copies of synthetic SARS- CoV-2 RNA (Twist Bioscience) in these primer comparisons. To optimize RT-LAMP for 2 6 3 ACTB, we used 5ng human RNA. RT-LAMP reactions were carried out at 65°C in a 2 6 4 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) thermocycler. 1 μ M SYTO 9 green fluorescent dye was used to track the time to result (TTR) in 2 6 5 min., deemed as the point at which the RFU (relative fluorescence units) curve crosses the 2 6 6 fluorescent threshold (green line, Fig 1D) . TTR values were plotted together with sensitivity (% 2 6 7 confirmed positives/ positives tested) and specificity (% confirmed negatives/negative controls 2 6 8 tested). The commercial RT-LAMP kit also contains phenol red, which changes from pink to 2 6 9 yellow with successful amplification, thus we also recorded color at the end of each experiment. displayed excellent TTR (~10-14 min), sensitivity (all 100% except Gene N2) and specificity (all 2 7 5 100%). The "TTTT" linker did not improve or impaired performance for 6/7 of the SARS-CoV-2 7 6 2 and the ACTB primers, and although it did improve detection with Gene N-A primers, these ACTB primers were much lower than those of the SARS-CoV-2 primers, and also exhibited a 2 7 9 lower TTR than viral primers (Figs 1F and 1G). In Phase 2, we increased replicates to 10 (from 4), and assessed 4 (rather than 1) viral 2 8 2 template amounts (30, 60, 120, 240 copies). We also assessed four template amounts for ACTB reactions (5 primer sets x 2 primer concentrations x 10 replicates x 4 template concentrations). The LoD is commonly defined as the concentration of analyte that can be detected in 95% of 2 8 6 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) 1 7 replicates [36], but as we used 10 replicates in this phase, we defined LoD as the lowest copy 2 8 7 number at which sensitivity was 100% after 30 min. Specificity was calculated using the no 2 8 8 template control (NTC) reactions at both 45 and 60 min. time points, which was used together 2 8 9 with the LoD to stratify primer sets (Fig 2A and S2 Fig). ORF1a, E1 and N2 primers at the 2 9 0 0.2/3.2/0.4 uM F3B3/FIPBIP/LFLB ratio were the top performers, with LoDs of 120, 240 and 2 9 1 240 copies, respectively and 100% specificity at 45 min (Fig 2A and S2D , S2A and S2C Figs). The alternate F3B3/FIPBIP/LFLB ratio for these primers also performed well, but the LoD 2 9 3 and/or specificity was marginally weaker ( primer set LoDs were similar to the E1 and N2 primers, but specificity was slightly worse at 60 was 100% at all four template concentrations. However, ACTB primer specificity was 100% vs. Multiplexed LAMP assays can be used to simultaneously test for multiple pathogens by labeling primers for different pathogens with different fluorophores [37, 38] . Here, we tested 3 1 2 whether multiplexing the best primer sets from Phase 2 (ORF1a, E1 and N2) improves detection template, and ran 10 replicates each to compare E1, N2 or ORF1a primer sets alone, or each of template copies, the N2 primer sets alone failed, while the E1 or ORF1a primer sets alone 3 1 9 exhibited < 50% sensitivity, and only the latter provided 100% specificity ( Fig 3A and S3A Fig) . Notably, each of the three primer set pairings improved sensitivity, and the best success rate of 3 2 1 70% success was achieved with the E1 + ORF1a combination, with a mean TTR of < 15 min, 3 2 2 and 100% specificity (Fig 3A) . At 60 min, 9/10 template reactions (90%) generated the 15 copies of SARS-CoV-2 RNA at the optimized concentration for each primer set (see Fig 2A 3 3 0 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. samples were not tested [27] . A separate study reported that GuHCl did not improve results with [40], can also enhance RT-LAMP [41, 42] . Thus, we tested whether GuHCl and/or betaine template amounts (7.5, 15, 20, 25 copies), which defined the LoD as 20 copies (2 copies/μl) 3 5 0 (Figs 3C and 3D). One out of 10 NTC reactions generated an aberrant signal, but again at 3 5 1 beyond 50 min. (Fig 3D) . Thus, the combination of E1 and ORF1a primers together with GuHCl . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) To test the efficiency of the maximized RT-LAMP in detecting SARS-CoV-2 RNA from 3 5 6 clinical patient samples, we tested 30 positive and 36 negative NP samples. RNA was extracted 3 5 7 and RT-PCR performed with the BGI RT-PCR kit, which is used in the clinic to detect SARS- LAMP was comparable to the BGI RT-PCR assay, with an AUC of 0.971 (95% CI: 0.896 -3 6 6 0.997) (P < 0.0001). The TTR at which the TPR + true negative rate (or 1-FPR) is highest was 3 6 7 13.2 minutes, and at that cutoff the sensitivity and specificity of RT-LAMP was 90% (95% CI: 73.5% -97.9%) and 100% (95% CI: 90.3% -100%), respectively. The latter satisfies a 65ºC in a water bath for 25 minutes using the end-point colorimetric method, and observed 3 7 5 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted February 27, 2022. RT-LAMP reaction is essentially as sensitive as the gold standard RT-PCR assay used in the 3 7 7 clinic, and can be performed using a method (heat source and detection) that is appropriate for 3 7 8 low-resource settings. as the cut-off to distinguish positive from negative samples with 100% specificity and sensitivity. . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted February 27, 2022. ; https://doi.org/10. 1101 /2022 To further validate the LAMP assay, it was evaluated in the National Institute of Public The above tests require access to appropriate resources to purify RNA. Next, therefore, (labeled #2-4 in Fig 5A) , which included no supplements, GuHCl alone, Betaine alone, or 4 1 8 GuHCl + Betaine and employed ROC curves to identify valid tests. Using a cutoff of P < 0.001, 4 1 9 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted February 27, 2022. ; https://doi.org/10.1101/2022.02.27.22271548 doi: medRxiv preprint 3 recommended for comparing ROC curves [45] , only Betaine (P < 0.0001) generated an AUC 4 2 0 (0.742) that was significantly different from a random test (Fig 5A) . Comparing the ROC curves 4 2 1 for each condition, the only significant difference was between Betaine alone and GuHCl alone 4 2 2 ( Fig 5A) . These results differed from those obtained with purified RNA, where combining 4 2 3 GuHCl and Betaine created a high-performance assay (Figs 3 and 4) . These data underscore the 4 2 4 importance of optimizing a PoC assay with raw clinical samples. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted February 27, 2022. Although ROC curve analyses confirmed that Betaine supplementation generates a useful 4 4 1 test, sensitivity was only 43.3% ( Fig 5A) . As a fifth condition (labeled #1 in Fig 5A) , we was 100% in both cases, but sensitivity and AUC increased to 53.3% and 0.771, respectively 4 4 5 ( Fig 5A) . However, this was not significantly different from Betaine alone (sensitivity 43.3%, LAMP TTR values on raw samples illustrated that the latter performed best on high titer (low Ct) To better define sensitivity around the approximate cutoff, we diluted high titer positives respectively, and all samples with a Ct ≥ 30.0 were false negatives ( Fig 5D) . In these Canadian samples, Ct values of 25, 27 and 30 corresponded to 7.9 X 10 6 , 2.5 X 10 6 and 3.2 X 10 5 copies of 4 6 1 SARS-CoV-2 per mL of raw NP samples respectively. Thus, the optimized RT-LAMP assay 4 6 2 used directly on 1 μ l of NP sample may be a useful screening tool to identify infectious 4 6 3 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted February 27, 2022. To test robustness, the assay was evaluated in the diagnostics laboratory, Universidad de ( Fig 6B) . Sensitivity was 91.4% (95% CI: 80.1% -96.6%) at Ct < 23, but dropped to 39.1% CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. Using the above TTR cutoff, a simulation test of direct RT-LAMP was then performed 4 9 4 with 208 randomly chosen samples (88 positive, 120 negative). We observed 100% specificity 30 were false negatives ( Fig 6D) . Overall, sensitivity in this setting with these randomly selected 5 0 0 samples was only 36.4%, below the 53.3% observed in the Canadian lab (Table 3 ). The . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) cutoff defined in this setting of 45 minutes ( Fig 6G) . As with the Canadian and Colombian data 5 0 9 sets, sensitivity was higher in samples with low Ct values ( Fig 6H) . ACTB was detected within 5 1 0 45 minutes in most of the samples (Fig 6I) . Together, these multi-centre studies suggest that this 5 1 1 direct RT-LAMP assay has utility as a PoC test to screen contagious individuals with high viral 5 1 2 loads to limit transmission. These data also highlight the real-world fluctuations in sensitivity The above direct RT-LAMP protocol removes the need for RNA extraction, but requires 5 1 6 a thermocycler. Thus, to further aid PoC testing, we tested a low cost combined incubator and is portable and can be operated on any global power supply using the correct plug adaptor, or a 5 2 5 portable 12V 10A battery (8-9 h), making it ideal for PoC testing. To interpret the results in FluoroPLUM, we used linear regression to measure "slope 20-40 " (Fig 7C) , as it provided easier 5 2 7 differentiation among positive and negative samples compared to TTR used in thermocyclers. Slope 20-40 is calculated using all the data points between 20 -40 mins, during which 5 2 9 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. Table 2 ) and, accordingly, was used in all subsequent assays. From slope 20-40 at which sensitivity + specificity is highest was 0.0004, and at that cutoff the sensitivity and specificity of RT-LAMP was 70% and 86%, respectively. The latter does not meet FDA used slope 20-40 > 0.0048 to define positives, as no false positives were detected above this cutoff. At this cutoff, sensitivity was 36.7% (95% CI: 21.9% to 54.5%), and specificity was 100% (95% 5 4 0 CI: 88.3% to 100%). Sensitivity was 100% (95% CI: 67.6% -100%) or 76.9% (95% CI: 49.7% -5 4 1 91.8%) for samples with Ct < 22.5 or Ct < 25 respectively, and fell to only 6.3% at Ct > 25 ( Fig 5 4 2 7E). In these raw samples, Ct at 22.5 and 25 reflects viral titer at 5.0 X 10 7 and 7.9 X 10 6 5 4 3 copies/mL respectively. These results were consistent with reaction color changes visualized at CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) samples was also demonstrated in labs in Colombia and Ecuador. In the former, an initial survey 100% specificity, and 90% sensitivity with high titer (Ct ≤ 23) samples. Overall, sensitivity in 6 2 0 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted February 27, 2022. ; https://doi.org/10.1101/2022.02.27.22271548 doi: medRxiv preprint the Bogota study was 33.4%, below the 55% seen in the Toronto lab. Human ACTB was 6 2 1 detected in more than 95% of the samples within 40 minutes. A smaller test in Ecuador with 21 personnel, and/or heat-inactivation of clinical samples (Table 3) . However, taken together, RT-6 2 7 LAMP brings the potential for deploying molecular testing broadly and, even with a detection 6 2 8 threshold limit of Ct 27, could provide significant gains for public health efforts to contain 6 2 9 infection. We compared our direct detection results to those of five other RT-LAMP studies ( Table 6 3 5 3). Dao Thi et al [21] , based in Heidelberg Germany, used N-A gene primers in RT-LAMP, and 6 3 6 observed sensitivity of ~47% at 99.5% specificity, which is in a similar range to each of our 6 3 7 three cohorts ( with randomly selected samples, above our best result of 53.3%, but specificity was only 89% in 6 4 0 contrast to 100% in our study (Table 3) . It would be interesting to run comparisons on the same . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) found the performance of some products was lower than what was experienced in Canada, likely 6 5 0 due to disruption of the cold chain during transport or customs clearance. Nation-specific 6 5 1 bureaucratic requirements can further delay reagent delivery; for example, the National Institute It is worth noting that Song et al also tested Penn-RAMP with virion RNA in a PoC 6 5 7 heating block [18], but whether this approach works with raw samples to the extent seen in the 6 5 8 dual-step tube format was not reported. Nevertheless, their data highlight the potential of using higher sensitivity at high Ct values is likely due to the polymerase used, which is extremely 6 6 5 thermostable and also provides sensitive reverse transcriptase activity. In their study, samples 6 6 6 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted February 27, 2022. assessed saliva rather than NP samples, which has the advantage of easier collection. They 6 6 8 observed 85% sensitivity at 100% specificity, but the highest RT-PCR Ct value of their samples 6 6 9 was only 28; indeed 100% sensitivity was only observed at Ct < 22.2 (Table 3) . Overall, RT-6 7 0 LAMP alone seems best suited to detect high titer samples. In the final phase of our diagnostic development program, we prototyped deployment of 6 7 2 the assay with a portable "lab-in-a-box" that provided combined incubation, optical monitoring viral loads (76.9% for Ct < 25 and 100% for Ct < 22.5), which dropped dramatically with low 6 7 5 viral loads (Ct > 25). Thus, most samples with viral load beyond 7.9 X 10 6 copies/mL could be 6 7 6 detected. These data were comparable to results obtained with thermocyclers, justifying future 6 7 7 work to assess this strategy in the field. Work is on-going to provide a more robust platform for 6 7 8 field testing to broaden accessibility of FluoroPLUM as a PoC device. Through the lens of maintaining public health, the priority is not necessarily to determine 6 8 0 whether a person has any evidence of SARS-CoV-2, but to quickly and accurately identify overall was 17%. Critically, at the lower viral load (10 6 copies per mL) the secondary attack rate 6 8 8 was 12% compared to 24% when the case had a viral load of 10 10 copies per mL or higher [55]. . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted February 27, 2022. ; https://doi.org/10. 1101 /2022 In comparison with our RT-LAMP assay, the detection sensitivity for samples with Ct < 25 6 9 0 (viral load > 7.9 X 10 6 copies per mL) was 76.9%, and 100% for samples with Ct ≤ 22.5 (viral 6 9 1 load ≥ 5 X 10 7 copies per mL), suggesting most individuals with high risk for transmission 6 9 2 would be identified. The turnaround time for laboratory-based RT-PCR testing is generally 24 to 6 9 3 48 hours, and longer in remote areas due to the transport of samples, while the RT-LAMP assay 6 9 4 would generate results on-site in less than one hour. Thus, our assay could potentially be 6 9 5 deployed as a PoC test at distributed sample collection centers to identify individuals with high 6 9 6 risk for transmission to mitigate virus spreading. A limitation of our study is that we tested NP swab samples processed in research a research project to locally produce easy-to-implement low-cost kits for the molecular diagnosis In summary, we developed a rapid RT-LAMP assay for SARS-CoV-2 detection which 7 1 1 was essentially as accurate as the BGI RT-PCR kit with extracted RNA, suggesting that it can 7 1 2 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted February 27, 2022. . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted February 27, 2022 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted February 27, 2022. . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted February 27, 2022. ; https://doi.org/10.1101/2022.02.27.22271548 doi: medRxiv preprint 0 d a t i o n o f l a b o r a t o r y -d e v e l o p e d m o l e c u l a r a s s a y s f o r i n f e c t i o u s d i s e a s e s . C l i n 8 1 7 M i c r o b i o l R e v . 2 0 1 0 ; 2 3 : 5 5 0 -5 7 6 . d o i : 1 0 . 1 1 2 8 / C M R . 0 0 0 7 4 -0 9 8 1 8 3 7 . F o o P C , C h a n Y Y , M o h a m e d M , W o n g W K , N u r u l N a j i a n A B , L i m B H . D e v e l o p m e n t o f a 8 1 9 t h e r m o s t a b i l i s e d t r i p l e x L A M P a s s a y w i t h d r y -r e a g e n t f o u r t a r g e t l a t e r a l f l o w d i p s t i c k f o r d e t e c t i o n 8 2 0 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted February 27, 2022. ; https://doi.org/10.1101 https://doi.org/10. /2022 1 4 9 . M a c K a y M J , H o o k e r A C , A f s h i n n e k o o E , S a l i t M , K e l l y J , F e l d s t e i n J V , e t a l . T h e C O V I D -1 9 X P R I Z E 8 5 4 a n d t h e n e e d f o r s c a l a b l e , f a s t , a n d w i d e s p r e a d t e s t i n g . N a t B i o t e c h n o l . 2 0 2 0 ; 3 8 : 1 0 2 1 -1 0 2 4 . 8 5 5 d o i : 1 0 . 1 0 3 8 / s 4 1 5 8 7 -0 2 0 -0 6 5 5 -4 8 5 6 5 0 . W o r l d H e a l t h O r g a n i z a t i o n . C O V I D -1 9 T a r g e t p r o d u c t p r o f i l e s f o r p r i o r i t y d i a g n o s t i c s t o s u p p o r t 8 5 7 r e s p o n s e t o t h e C O V I D -1 9 . Supporting information CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted February 27, 2022. ; https://doi.org/10.1101 https://doi.org/10. /2022 ORF1a 0.2/3.2/0.4 4/10 9/10 10/10 10/10 120 10/10 6/10 0.2/1.6/0.4 3/10 5/10 8/10 10/10 240 9/10 6/10 Gene E1 0.2/3.2/0.4 4/10 9/10 9/10 10/10 240 10/10 10/10 0.2/1.6/0.8 3/10 6/10 9/10 10/10 240 10/10 7/10 5 μM 10 μM